Eye Diseases
Showing NaN - NaN of 5
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Completed
- Presbyopia
- +2 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +4 more
Oct 18, 2022
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Recruiting
- Presbyopia
- +4 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +3 more
Aug 3, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Ischemia, Retinal Vein Occlusion, Pathologic Processes Trial in Houston (ranibizumab)
Terminated
- Ischemia
- +4 more
-
Houston, TexasRetina Consultants of Houston
May 2, 2017
Eye Diseases Trial in Worldwide (Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Suspension Depot, 30 mg/mL,
Completed
- Eye Diseases
- Anecortave Acetate Sterile Suspension, 6 mg/mL
- +3 more
-
Jacksonville, Florida
- +11 more
Nov 27, 2012